A Randomized, Active Control, Parallel Study to Evaluate the Efficacy and Safety of Zolpidem MR (Stilnox CR) Versus Zolpidem (Stilnox) in Patients With Primary Insomnia.
Phase of Trial: Phase IV
Latest Information Update: 05 Oct 2011
At a glance
- Drugs Zolpidem (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 05 Oct 2011 Actual end date (April 2011) added as reported by ClinicalTrials.gov.
- 05 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Aug 2010 New trial record